These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 18393387

  • 1. Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma.
    Ho JC, Ip YC, Cheung ST, Lee YT, Chan KF, Wong SY, Fan ST.
    Hepatology; 2008 May; 47(5):1524-32. PubMed ID: 18393387
    [Abstract] [Full Text] [Related]

  • 2. RNA interference against granulin-epithelin precursor prevents hepatocellular carcinoma growth: its application as a therapeutic agent.
    Park MY, Park YS, Nam JH.
    Int J Oncol; 2011 Oct; 39(4):853-61. PubMed ID: 21701774
    [Abstract] [Full Text] [Related]

  • 3. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma.
    Cheung ST, Wong SY, Leung KL, Chen X, So S, Ng IO, Fan ST.
    Clin Cancer Res; 2004 Nov 15; 10(22):7629-36. PubMed ID: 15569995
    [Abstract] [Full Text] [Related]

  • 4. Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity.
    Cheung PF, Yip CW, Wong NC, Fong DY, Ng LW, Wan AM, Wong CK, Cheung TT, Ng IO, Poon RT, Fan ST, Cheung ST.
    Cancer Immunol Res; 2014 Dec 15; 2(12):1209-19. PubMed ID: 25315249
    [Abstract] [Full Text] [Related]

  • 5. Antibody against granulin-epithelin precursor sensitizes hepatocellular carcinoma to chemotherapeutic agents.
    Wong NC, Cheung PF, Yip CW, Chan KF, Ng IO, Fan ST, Cheung ST.
    Mol Cancer Ther; 2014 Dec 15; 13(12):3001-12. PubMed ID: 25253787
    [Abstract] [Full Text] [Related]

  • 6. GEP associates with wild-type p53 in hepatocellular carcinoma.
    Cheung ST, Wong SY, Lee YT, Fan ST.
    Oncol Rep; 2006 Jun 15; 15(6):1507-11. PubMed ID: 16685387
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC, Ye SL, Sun RX, Liu YK, Tang ZY, Kim Y, Karras JG, Zhang H.
    Clin Cancer Res; 2006 Dec 01; 12(23):7140-8. PubMed ID: 17145839
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of PC cell-derived growth factor (PCDGF)/granulin-epithelin precursor (GEP) decreased cell proliferation and invasion through downregulation of cyclin D and CDK4 and inactivation of MMP-2.
    Liu Y, Xi L, Liao G, Wang W, Tian X, Wang B, Chen G, Han Z, Wu M, Wang S, Zhou J, Xu G, Lu Y, Ma D.
    BMC Cancer; 2007 Jan 29; 7():22. PubMed ID: 17261172
    [Abstract] [Full Text] [Related]

  • 9. Granulin-epithelin precursor interacts with 78-kDa glucose-regulated protein in hepatocellular carcinoma.
    Yip CW, Lam CY, Poon TCW, Cheung TT, Cheung PFY, Fung SW, Wang XQ, Leung ICY, Ng LWC, Lo CM, Tsao GSW, Cheung ST.
    BMC Cancer; 2017 Jun 10; 17(1):409. PubMed ID: 28601093
    [Abstract] [Full Text] [Related]

  • 10. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
    Liu Y, Poon RT, Li Q, Kok TW, Lau C, Fan ST.
    Cancer Res; 2005 May 01; 65(9):3691-9. PubMed ID: 15867364
    [Abstract] [Full Text] [Related]

  • 11. Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma.
    Cheung PF, Cheung TT, Yip CW, Ng LW, Fung SW, Lo CM, Fan ST, Cheung ST.
    Oncotarget; 2016 Apr 19; 7(16):21644-57. PubMed ID: 26942873
    [Abstract] [Full Text] [Related]

  • 12. Suppression of tumor proliferation and angiogenesis of hepatocellular carcinoma by HS-104, a novel phosphoinositide 3-kinase inhibitor.
    Jung KH, Zheng HM, Jeong Y, Choi MJ, Lee H, Hong SW, Lee HS, Son MK, Lee S, Hong S, Hong SS.
    Cancer Lett; 2013 Jan 01; 328(1):176-87. PubMed ID: 22902995
    [Abstract] [Full Text] [Related]

  • 13. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
    Prewett M, Huber J, Li Y, Santiago A, O'Connor W, King K, Overholser J, Hooper A, Pytowski B, Witte L, Bohlen P, Hicklin DJ.
    Cancer Res; 1999 Oct 15; 59(20):5209-18. PubMed ID: 10537299
    [Abstract] [Full Text] [Related]

  • 14. Granulin-epithelin precursor is an oncofetal protein defining hepatic cancer stem cells.
    Cheung PF, Cheng CK, Wong NC, Ho JC, Yip CW, Lui VC, Cheung AN, Fan ST, Cheung ST.
    PLoS One; 2011 Oct 15; 6(12):e28246. PubMed ID: 22194816
    [Abstract] [Full Text] [Related]

  • 15. Granulin-epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance.
    Cheung ST, Cheung PF, Cheng CK, Wong NC, Fan ST.
    Gastroenterology; 2011 Jan 15; 140(1):344-55. PubMed ID: 20682318
    [Abstract] [Full Text] [Related]

  • 16. Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma.
    Wang Z, Zhou J, Fan J, Qiu SJ, Yu Y, Huang XW, Tang ZY.
    Clin Cancer Res; 2008 Aug 15; 14(16):5124-30. PubMed ID: 18698030
    [Abstract] [Full Text] [Related]

  • 17. The granulin-epithelin precursor is a steroid-regulated growth factor in endometrial cancer.
    Jones MB, Houwink AP, Freeman BK, Greenwood TM, Lafky JM, Lingle WL, Berchuck A, Maxwell GL, Podratz KC, Maihle NJ.
    J Soc Gynecol Investig; 2006 May 15; 13(4):304-11. PubMed ID: 16697948
    [Abstract] [Full Text] [Related]

  • 18. Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.
    Huynh H, Ngo VC, Fargnoli J, Ayers M, Soo KC, Koong HN, Thng CH, Ong HS, Chung A, Chow P, Pollock P, Byron S, Tran E.
    Clin Cancer Res; 2008 Oct 01; 14(19):6146-53. PubMed ID: 18829493
    [Abstract] [Full Text] [Related]

  • 19. Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling.
    Man K, Ng KT, Xu A, Cheng Q, Lo CM, Xiao JW, Sun BS, Lim ZX, Cheung JS, Wu EX, Sun CK, Poon RT, Fan ST.
    Clin Cancer Res; 2010 Feb 01; 16(3):967-77. PubMed ID: 20103676
    [Abstract] [Full Text] [Related]

  • 20. Anti-cancer mechanisms of clinically acceptable colchicine concentrations on hepatocellular carcinoma.
    Lin ZY, Wu CC, Chuang YH, Chuang WL.
    Life Sci; 2013 Sep 03; 93(8):323-8. PubMed ID: 23871804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.